CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) today announced that it will provide an overview of its drug discovery and development programs targeted to Toll-like Receptors and a general corporate update at the Noble Financial Capital Markets’ Seventh Annual Equity Conference on Tuesday, May 17, 2011 at 8:30 a.m. ET at the Hard Rock Hotel in Hollywood, Florida.